G360-IIT · Immune Profile Selection By Fraction of ctDNA · Advanced NSCLC Treated With Immunotherapy
Trial terminated
Also in this update: Final enrollment: 5 participants — 5% of the 108 planned; Primary completion date changed from estimate of Apr 28, 2027 to Aug 13, 2026
Hackensack Meridian HealthPhase 2 NCT05715229 Registry history of NCT05715229 on ClinicalTrials.gov (opens the registry)